Cargando…

Uric Acid as a Risk Factor for Cardiovascular Disease and Mortality in Overweight/Obese Individuals

BACKGROUND: The predictive value of serum uric acid (SUA) for adverse cardiovascular events among obese and overweight patients is not known, but potentially important because of the relation between hyperuricaemia and obesity. METHODS: The relationship between SUA and risk of cardiovascular adverse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skak-Nielsen, Helle, Torp-Pedersen, Christian, Finer, Nick, Caterson, Ian D., Van Gaal, Luc, James, W. Philip T, Maggioni, Aldo Pietro, Sharma, Arya M., Coutinho, Walmir, Andersson, Charlotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606441/ https://www.ncbi.nlm.nih.gov/pubmed/23533601 http://dx.doi.org/10.1371/journal.pone.0059121

Ejemplares similares

Association of Hypoglycemic Treatment Regimens With Cardiovascular Outcomes in Overweight and Obese Subjects With Type 2 Diabetes: A substudy of the SCOUT trial
por: Ghotbi, Adam Ali, et al.
Publicado: (2013)

Differential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trial
por: Andersson, Charlotte, et al.
Publicado: (2009)

The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period
por: Weeke, Peter, et al.
Publicado: (2010)

Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons
por: Sahlberg, Marie, et al.
Publicado: (2015)

Impact of Dietary Fats on Cardiovascular Disease with a Specific Focus on Omega-3 Fatty Acids
por: Maggioni, Aldo Pietro, et al.
Publicado: (2022)

Cardiovascular comorbidities as predictors for severe COVID-19 infection or death
por: Phelps, Matthew, et al.
Publicado: (2020)

Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study
por: Butt, Sheraz A., et al.
Publicado: (2019)

Body mass index and risk of perioperative cardiovascular adverse events and mortality in 34,744 Danish patients undergoing hip or knee replacement
por: Thornqvist, Catharina, et al.
Publicado: (2014)

Liraglutide and cardiovascular outcomes in adults with overweight or obesity: A post hoc analysis from SCALE randomized controlled trials
por: Davies, M. J., et al.
Publicado: (2017)

Debate: Should statin be used in patients with heart failure?
por: Pietro Maggioni, Aldo
Publicado: (2001)

Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Patients with Overweight/Obesity
por: She, Dunmin, et al.
Publicado: (2023)

Cause-Specific Cardiovascular Risk Associated with Nonsteroidal Anti-Inflammatory Drugs among Myocardial Infarction Patients - A Nationwide Study
por: Schjerning Olsen, Anne-Marie, et al.
Publicado: (2013)

Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk
por: Grassi, Davide, et al.
Publicado: (2013)

Confounders of uric acid level for assessing cardiovascular outcomes
por: Dogan, Mehmet, et al.
Publicado: (2016)

Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Project
por: Russo, Elisa, et al.
Publicado: (2021)

Cardiovascular Morbidity in Monoclonal Gammopathy of Undetermined Significance: A Danish Nationwide Study
por: Schwartz, Brian, et al.
Publicado: (2022)

Creatinine, total cysteine and uric acid are associated with serum retinol in patients with cardiovascular disease
por: Olsen, Thomas, et al.
Publicado: (2019)

The Effect of Exercise on Visceral Adipose Tissue in Overweight Adults: A Systematic Review and Meta-Analysis
por: Vissers, Dirk, et al.
Publicado: (2013)

Systolic Blood Pressure and Outcome in Patients Admitted With Acute Heart Failure: An Analysis of Individual Patient Data From 4 Randomized Clinical Trials
por: Grand, Johannes, et al.
Publicado: (2021)

Osteopontin as Candidate Biomarker of Coronary Disease despite Low Cardiovascular Risk: Insights from CAPIRE Study
por: Carbone, Federico, et al.
Publicado: (2022)

Evaluation of high‐sensitivity C‐reactive protein and uric acid in vericiguat‐treated patients with heart failure with reduced ejection fraction
por: Kramer, Frank, et al.
Publicado: (2020)

Sleep disordered breathing and autonomic function in overweight and obese children and adolescents
por: Van Eyck, Annelies, et al.
Publicado: (2016)

Continuous Exercise but Not High Intensity Interval Training Improves Fat Distribution in Overweight Adults
por: Keating, Shelley E., et al.
Publicado: (2014)

Uric Acid for Cardiovascular Risk: Dr. Jekyll or Mr. Hide?
por: Vassalle, Cristina, et al.
Publicado: (2016)

Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study
por: Norvik, Jon V., et al.
Publicado: (2016)

Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children
por: Özalp Kızılay, Deniz, et al.
Publicado: (2019)

Uric acid versus metabolic syndrome as markers of fatty liver disease in young people with overweight/obesity
por: Di Bonito, Procolo, et al.
Publicado: (2022)

Increased susceptibility to cardiovascular effects of dihydrocapcaicin in resuscitated rats. Cardiovascular effects of dihydrocapsaicin
por: Fosgerau, Keld, et al.
Publicado: (2010)

Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study
por: Bretler, Ditte-Marie, et al.
Publicado: (2012)

Overweight, the Cardiovascular Risk of the Century
por: Jardim, Paulo César B. Veiga
Publicado: (2019)

Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial
por: Parker, Helen M., et al.
Publicado: (2019)

Infancy weight gain, parental socioeconomic position, and childhood overweight and obesity: a Danish register-based cohort study
por: Rotevatn, Torill Alise, et al.
Publicado: (2019)

A genome wide association study of plasma uric acid levels in obese cases and never-overweight controls
por: Li, Wei-Dong, et al.
Publicado: (2013)

Uric Acid and Potassium Serum Levels Are Independent Predictors of Blood Pressure Non-Dipping in Overweight or Obese Subjects
por: Zupo, Roberta, et al.
Publicado: (2019)

Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity
por: Jordan, Jens, et al.
Publicado: (2014)

Potential Role of Uric Acid as a Risk Factor for Cardiovascular Disease
por: Kang, Duk-Hee
Publicado: (2010)

Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review
por: Sharaf El Din, Usama A.A., et al.
Publicado: (2017)

Association of Serum Uric Acid with Cardiovascular Disease Risk Scores in Koreans
por: Lee, Seung Yun, et al.
Publicado: (2019)

Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment
por: Gherghina, Mihai-Emil, et al.
Publicado: (2022)

Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
por: Ying, Hangying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aqbt8t0a5f0knlefigrv7oqqf0